Evolution of the Average Target: Merck & Co., Inc.

Evolution of the Target Price: Merck & Co., Inc.

Changes in Analyst Recommendations: Merck & Co., Inc.

d6a.Ytig66C2TX-RAgcggcm_ym_02IFmtaMJ7lvEU6sb2Bs.DYHhuZaBHkimWDFMy6Xvoy6AiLcz-cU7mTSGa5hMsHUgtv-g1dE7JvB0Mw~92f8cb85f617cbbc832fef8890219d30
Guggenheim Adjusts Price Target on Merck & Co. to $115 From $122 09:43am MT
HSBC Adjusts Price Target on Merck to $115 From $130 02-11 MT
Bernstein Adjusts Price Target on Merck & Co. to $95 From $110, Keeps Market Perform Rating 02-11 MT
TD Cowen Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $100 From $121 02-10 MT
UBS Adjusts Price Target on Merck to $105 From $120, Maintains Buy Rating 02-05 MT
Wells Fargo Adjusts Merck Price Target to $97 From $110 02-05 MT
Citigroup Adjusts Merck Price Target to $115 From $125 02-05 MT
Jefferies Adjusts Merck Price Target to $138 From $150 02-05 MT
JPMorgan Adjusts Merck Price Target to $130 From $145 02-05 MT
Daiwa Securities Adjusts Merck Price Target to $95 From $100 02-05 MT
Goldman Sachs Adjusts Merck Price Target to $129 From $135 02-05 MT
Leerink Partners Adjusts Merck Price Target to $113 From $118 02-05 MT
Deutsche Bank Adjusts Merck Price Target to $128 From $132, Maintains Buy Rating 02-05 MT
Morgan Stanley Trims Price Target on Merck to $106 From $113, Keeps Equalweight Rating 02-05 MT
Deutsche Bank Adjusts Price Target on Merck to $132 From $140 02-04 MT
Analysts recommendations: Accenture, Lockheed Martin, Hershey, Tapestry, Occidental Petroleum... 01-31Our Logo
Analysts recommendations: Wizz Air, Glencore, J Sainsbury, Merck, Occidental Petroleum… 01-31Our Logo
Citigroup Adjusts Price Target on Merck & Co. to $125 From $130, Keeps Buy Rating 01-28 MT
TD Cowen Adjusts Price Target on Merck to $121 From $140 01-27 MT
Leerink Partners Adjusts Merck Price Target to $118 From $119, Maintains Outperform Rating 01-24 MT
Morgan Stanley Adjusts Merck Price Target to $113 From $123, Maintains Equal Weight Rating 01-21 MT
Guggenheim Adjusts Price Target on Merck to $122 From $130, Maintains Buy Rating 01-17 MT
Leerink Partners Adjusts Price Target on Merck $119 From $136, Keeps Outperform Rating 01-13 MT
UBS Cuts Price Target on Merck to $120 From $125, Maintains Buy Rating 01-08 MT
Analyst recommendations: Adobe, Merck, Take-Two, Palantir, Experian... 01-08Our Logo
More recommendations

Add to a list
Consensus 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+34.82%
+13.28%
+8.01%
+37.7%
+6.81%
+6.64%
+20.92%
+6.71%
+6.75%
+22.11%
Average +16.38%
Weighted average by Cap. +16.02%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
86.54USD
Average target price
116.67USD
Spread / Average Target
+34.82%
High Price Target
148.00USD
Spread / Highest target
+71.02%
Low Price Target
95.00USD
Spread / Lowest Target
+9.78%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HSBC
Bernstein
TD Cowen
UBS
JPMorgan Chase
Leerink Partners
Goldman Sachs
Daiwa Securities
Jefferies & Co.
Citigroup
Wells Fargo Securities
Deutsche Bank Securities
Morgan Stanley
Guggenheim
Truist Securities
BMO Capital
Berenberg Bank
CFRA
Argus
Barclays
Redburn Atlantic
Wolfe Research
Cantor Fitzgerald
Zacks Investment Research
Societe Generale
BofA Securities
Atlantic Equities
Credit Suisse
SVB Securities LLC
Cowen
SVB Leerink
RBC Capital Markets
RBC Randall Stanicky
JPMORGAN
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Consensus Merck & Co., Inc.